首页 | 本学科首页   官方微博 | 高级检索  
     


A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
Authors:Naohiro Izawa  Seiichi Matsumoto  Jun Manabe  Taisuke Tanizawa  Manabu Hoshi  Toshio Shigemitsu  Rikuo Machinami  Hiroaki Kanda  Kengo Takeuchi  Yoshio Miki  Masami Arai  Shuya Shirahama  Noriyoshi Kawaguchi
Affiliation:(1) Department of Orthopedic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan;(2) Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan;(3) Department of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan;(4) Center for Molecular Biology and Cytogenetics, SRL Inc., Tokyo, Japan
Abstract:
We describe a patient who had nine primary malignant tumors and a germline mutation in the p53 tumor-suppressor gene, characteristically found in the Li-Fraumeni syndrome (LFS). A 15-year-old girl with no family history of cancer was referred to our hospital because of pain and swelling of the right knee. Osteosarcoma was diagnosed. The patient received chemotherapy followed by surgery and had a remission. After the age of 28 years, nine primary malignant tumors developed successively, including right breast cancer, colon cancer, malignant fibrous histiocytoma (MFH) of the abdominal wall, right lung double cancers, bilateral breast cancers, and MFH of the left thigh. This is the second highest number of types of primary malignant tumors to be reported in LFS. All tumors were treated by a multidisciplinary approach, including surgery. Genetic analysis revealed a germline missense mutation in the p53 gene (c.659 A > G), resulting in Y220C, which has been reported in three families with LFS. The patient died of lung metastasis from MFH at the age of 37 years. Despite the multiple tumors, repeated induction of remissions resulted in long survival. Our findings suggest that a multidisciplinary approach to treatment, including surgery, is beneficial in patients with LFS.
Keywords:p53   Germline mutation  Multiple primary malignancies  Li-Fraumeni syndrome
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号